|
PHLPP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.435810E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.136400E-02 |
| Normal-vs-Stage2 |
2.312000E-01 |
| Normal-vs-Stage3 |
2.567500E-02 |
| Normal-vs-Stage4 |
8.221800E-01 |
| Stage1-vs-Stage2 |
8.057400E-01 |
| Stage1-vs-Stage3 |
1.561420E-01 |
| Stage1-vs-Stage4 |
4.000200E-01 |
| Stage2-vs-Stage3 |
4.426000E-01 |
| Stage2-vs-Stage4 |
3.397600E-01 |
| Stage3-vs-Stage4 |
5.112300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.020500E-03 |
| Normal-vs-AfricanAmerican |
2.127800E-01 |
| Normal-vs-Asian |
2.237800E-01 |
| Caucasian-vs-AfricanAmerican |
4.235000E-01 |
| Caucasian-vs-Asian |
5.375600E-01 |
| AfricanAmerican-vs-Asian |
3.509800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.722100E-02 |
| Normal-vs-Female |
1.521120E-03 |
| Male-vs-Female |
4.876500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.771000E-01 |
| Normal-vs-Extreme_Weight |
7.396000E-01 |
| Normal-vs-Obese |
1.215610E-02 |
| Normal-vs-Extreme_Obese |
9.696400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.629200E-01 |
| Normal_Weight-vs-Obese |
2.408000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.782400E-01 |
| Extreme_Weight-vs-Obese |
1.848430E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.158400E-01 |
| Obese-vs-Extreme_Obese |
1.022200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.210100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.142400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.135420E-01 |
| Normal-vs-Age(81-100Yrs) |
9.156200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.696170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.714300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.516000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.401380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.811590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.235000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.307700E-02 |
| Normal-VS-Type2 PRCC |
6.150000E-02 |
| Normal-VS-KIRP CIMP |
3.554200E-02 |
| Normal-VS-Unclassified PRCC |
3.797800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.486000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.515800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.347600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.157640E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.942200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.992980E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.503050E-01 |
| Normal-vs-N1 |
4.889700E-02 |
| Normal-vs-N2 |
2.392100E-02 |
| N0-vs-N1 |
3.803000E-01 |
| N0-vs-N2 |
2.087400E-01 |
| N1-vs-N2 |
1.081210E-01 |
|
|
